Concepts (235)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Hip | 40 | 2022 | 349 | 4.740 |
Why?
|
| Arthroplasty, Replacement, Knee | 30 | 2022 | 264 | 4.700 |
Why?
|
| Prosthesis-Related Infections | 18 | 2020 | 98 | 3.540 |
Why?
|
| Prosthesis Failure | 23 | 2020 | 229 | 2.890 |
Why?
|
| Hip Prosthesis | 24 | 2020 | 248 | 2.780 |
Why?
|
| Reoperation | 34 | 2020 | 366 | 1.870 |
Why?
|
| Acetabulum | 8 | 2020 | 81 | 1.620 |
Why?
|
| Arthritis, Infectious | 6 | 2020 | 32 | 1.580 |
Why?
|
| Knee Joint | 12 | 2021 | 284 | 1.480 |
Why?
|
| Knee Prosthesis | 11 | 2021 | 92 | 1.460 |
Why?
|
| Femur | 11 | 2019 | 190 | 1.390 |
Why?
|
| Anti-Bacterial Agents | 5 | 2020 | 207 | 1.210 |
Why?
|
| Humans | 69 | 2022 | 12240 | 1.160 |
Why?
|
| Aged | 43 | 2022 | 4000 | 1.140 |
Why?
|
| Bone Cements | 5 | 2020 | 37 | 1.110 |
Why?
|
| Prosthesis Design | 11 | 2019 | 195 | 1.090 |
Why?
|
| Hip Joint | 9 | 2020 | 136 | 1.030 |
Why?
|
| Postoperative Complications | 10 | 2018 | 385 | 1.010 |
Why?
|
| Male | 44 | 2020 | 6815 | 0.980 |
Why?
|
| Osteolysis | 5 | 2010 | 66 | 0.980 |
Why?
|
| Female | 43 | 2020 | 6974 | 0.940 |
Why?
|
| Middle Aged | 38 | 2020 | 4043 | 0.900 |
Why?
|
| Joint Diseases | 4 | 2021 | 44 | 0.800 |
Why?
|
| Tibia | 6 | 2017 | 100 | 0.800 |
Why?
|
| Retrospective Studies | 25 | 2021 | 1467 | 0.790 |
Why?
|
| Aged, 80 and over | 29 | 2018 | 2152 | 0.780 |
Why?
|
| Periprosthetic Fractures | 4 | 2019 | 19 | 0.760 |
Why?
|
| Hip Dislocation | 7 | 2016 | 30 | 0.740 |
Why?
|
| Bone Resorption | 4 | 2014 | 55 | 0.740 |
Why?
|
| Radiography | 13 | 2019 | 258 | 0.700 |
Why?
|
| Pain, Postoperative | 5 | 2022 | 146 | 0.680 |
Why?
|
| Tobramycin | 2 | 2018 | 5 | 0.660 |
Why?
|
| Vancomycin | 2 | 2018 | 18 | 0.660 |
Why?
|
| Gentamicins | 2 | 2018 | 17 | 0.660 |
Why?
|
| Joint Instability | 3 | 2018 | 145 | 0.630 |
Why?
|
| Decision Support Techniques | 2 | 2011 | 24 | 0.560 |
Why?
|
| Treatment Outcome | 22 | 2019 | 1478 | 0.550 |
Why?
|
| Radiostereometric Analysis | 1 | 2018 | 2 | 0.550 |
Why?
|
| Population Surveillance | 1 | 2018 | 46 | 0.540 |
Why?
|
| Acute Kidney Injury | 1 | 2018 | 25 | 0.530 |
Why?
|
| Leg Length Inequality | 1 | 2016 | 6 | 0.500 |
Why?
|
| Follow-Up Studies | 12 | 2019 | 726 | 0.470 |
Why?
|
| Incidence | 7 | 2018 | 338 | 0.440 |
Why?
|
| Prospective Studies | 7 | 2018 | 817 | 0.430 |
Why?
|
| Decision Trees | 2 | 2011 | 7 | 0.410 |
Why?
|
| Metals | 2 | 2012 | 56 | 0.400 |
Why?
|
| Risk Factors | 9 | 2019 | 1049 | 0.390 |
Why?
|
| Polymethyl Methacrylate | 2 | 2011 | 8 | 0.390 |
Why?
|
| Osteoarthritis, Knee | 4 | 2021 | 169 | 0.390 |
Why?
|
| Tantalum | 4 | 2018 | 11 | 0.380 |
Why?
|
| Perioperative Care | 3 | 2017 | 24 | 0.380 |
Why?
|
| Antirheumatic Agents | 3 | 2017 | 40 | 0.380 |
Why?
|
| Pelvic Bones | 1 | 2012 | 6 | 0.370 |
Why?
|
| Adult | 21 | 2017 | 3557 | 0.370 |
Why?
|
| Ketamine | 2 | 2022 | 18 | 0.360 |
Why?
|
| Osseointegration | 4 | 2016 | 53 | 0.360 |
Why?
|
| Quality of Life | 2 | 2011 | 261 | 0.340 |
Why?
|
| Prostheses and Implants | 1 | 2010 | 92 | 0.300 |
Why?
|
| Synovial Fluid | 6 | 2016 | 53 | 0.290 |
Why?
|
| Rheumatology | 3 | 2017 | 42 | 0.280 |
Why?
|
| Patient Discharge | 1 | 2009 | 77 | 0.280 |
Why?
|
| Coated Materials, Biocompatible | 2 | 2005 | 21 | 0.270 |
Why?
|
| Demography | 2 | 2017 | 37 | 0.260 |
Why?
|
| Time Factors | 8 | 2020 | 695 | 0.250 |
Why?
|
| Surgeons | 3 | 2022 | 43 | 0.240 |
Why?
|
| Osteotomy | 3 | 2014 | 66 | 0.230 |
Why?
|
| Arthroplasty, Replacement | 1 | 2006 | 49 | 0.220 |
Why?
|
| United States | 9 | 2022 | 989 | 0.220 |
Why?
|
| Cementation | 1 | 2005 | 19 | 0.220 |
Why?
|
| Feasibility Studies | 2 | 2018 | 113 | 0.200 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2003 | 3 | 0.190 |
Why?
|
| C-Reactive Protein | 5 | 2016 | 54 | 0.190 |
Why?
|
| Case-Control Studies | 2 | 2018 | 256 | 0.190 |
Why?
|
| Anesthesia, Conduction | 1 | 2022 | 15 | 0.180 |
Why?
|
| Orthopedic Surgeons | 1 | 2022 | 9 | 0.180 |
Why?
|
| Foreign Bodies | 1 | 2002 | 16 | 0.180 |
Why?
|
| Odds Ratio | 2 | 2019 | 115 | 0.170 |
Why?
|
| Elective Surgical Procedures | 2 | 2018 | 14 | 0.170 |
Why?
|
| Bone Nails | 1 | 2020 | 8 | 0.160 |
Why?
|
| Arthrodesis | 1 | 2020 | 17 | 0.160 |
Why?
|
| Glucocorticoids | 2 | 2017 | 35 | 0.160 |
Why?
|
| Biomechanical Phenomena | 4 | 2021 | 297 | 0.160 |
Why?
|
| Rheumatic Diseases | 2 | 2017 | 30 | 0.160 |
Why?
|
| Femoral Fractures | 1 | 2019 | 17 | 0.150 |
Why?
|
| Illinois | 2 | 2018 | 110 | 0.150 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2019 | 6 | 0.150 |
Why?
|
| Physical Examination | 1 | 2019 | 37 | 0.150 |
Why?
|
| Recovery of Function | 5 | 2012 | 118 | 0.150 |
Why?
|
| Treatment Failure | 1 | 2019 | 58 | 0.150 |
Why?
|
| Risk Assessment | 5 | 2012 | 295 | 0.150 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 151 | 0.150 |
Why?
|
| Therapeutic Irrigation | 3 | 2019 | 27 | 0.150 |
Why?
|
| Arthroplasty | 2 | 2022 | 54 | 0.140 |
Why?
|
| Microspheres | 1 | 2018 | 12 | 0.140 |
Why?
|
| Creatinine | 1 | 2018 | 29 | 0.140 |
Why?
|
| Absorption, Physiological | 1 | 2017 | 2 | 0.130 |
Why?
|
| Knee | 1 | 2017 | 16 | 0.130 |
Why?
|
| Regression Analysis | 1 | 2017 | 105 | 0.130 |
Why?
|
| Leukocyte Count | 5 | 2016 | 35 | 0.130 |
Why?
|
| Biological Products | 1 | 2017 | 16 | 0.130 |
Why?
|
| Blood Sedimentation | 5 | 2016 | 26 | 0.130 |
Why?
|
| Kidney | 1 | 2017 | 87 | 0.130 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 61 | 0.130 |
Why?
|
| Biocompatible Materials | 2 | 2017 | 42 | 0.120 |
Why?
|
| Disease Management | 2 | 2017 | 59 | 0.120 |
Why?
|
| Algorithms | 4 | 2017 | 169 | 0.120 |
Why?
|
| Self Concept | 1 | 2016 | 26 | 0.120 |
Why?
|
| Povidone-Iodine | 2 | 2019 | 5 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 116 | 0.120 |
Why?
|
| Postoperative Period | 1 | 2016 | 118 | 0.120 |
Why?
|
| Porosity | 3 | 2012 | 33 | 0.120 |
Why?
|
| Patella | 2 | 2015 | 24 | 0.120 |
Why?
|
| Metal-on-Metal Joint Prostheses | 1 | 2015 | 14 | 0.110 |
Why?
|
| Debridement | 2 | 2011 | 31 | 0.110 |
Why?
|
| Intraoperative Complications | 2 | 2013 | 29 | 0.110 |
Why?
|
| Allografts | 1 | 2015 | 74 | 0.110 |
Why?
|
| Observer Variation | 1 | 2014 | 47 | 0.100 |
Why?
|
| Prevalence | 2 | 2011 | 175 | 0.100 |
Why?
|
| ROC Curve | 4 | 2016 | 78 | 0.090 |
Why?
|
| Tibial Fractures | 1 | 2012 | 4 | 0.090 |
Why?
|
| Braces | 1 | 2012 | 9 | 0.090 |
Why?
|
| Equipment Failure Analysis | 1 | 2011 | 32 | 0.090 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2017 | 132 | 0.090 |
Why?
|
| Tendons | 1 | 2012 | 74 | 0.090 |
Why?
|
| Predictive Value of Tests | 4 | 2014 | 218 | 0.080 |
Why?
|
| Serologic Tests | 1 | 2011 | 6 | 0.080 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2011 | 26 | 0.080 |
Why?
|
| Sensitivity and Specificity | 4 | 2015 | 252 | 0.080 |
Why?
|
| Infection Control | 1 | 2011 | 76 | 0.080 |
Why?
|
| Transplantation, Homologous | 2 | 2012 | 93 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2017 | 85 | 0.080 |
Why?
|
| Cohort Studies | 3 | 2012 | 827 | 0.080 |
Why?
|
| Bone Transplantation | 2 | 2012 | 82 | 0.080 |
Why?
|
| Device Removal | 2 | 2011 | 32 | 0.070 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2011 | 142 | 0.070 |
Why?
|
| Anesthesia | 1 | 2009 | 19 | 0.070 |
Why?
|
| Ambulatory Care | 1 | 2009 | 36 | 0.070 |
Why?
|
| Patient Care Team | 1 | 2009 | 52 | 0.070 |
Why?
|
| Hip Fractures | 1 | 2008 | 18 | 0.070 |
Why?
|
| Range of Motion, Articular | 3 | 2015 | 278 | 0.070 |
Why?
|
| Arthritis, Juvenile | 2 | 2017 | 6 | 0.060 |
Why?
|
| Piperidines | 2 | 2017 | 10 | 0.060 |
Why?
|
| Pyrimidines | 2 | 2017 | 16 | 0.060 |
Why?
|
| Pyrroles | 2 | 2017 | 15 | 0.060 |
Why?
|
| Spondylitis, Ankylosing | 2 | 2017 | 11 | 0.060 |
Why?
|
| Arthritis, Psoriatic | 2 | 2017 | 11 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2014 | 423 | 0.060 |
Why?
|
| Age Distribution | 2 | 2005 | 25 | 0.060 |
Why?
|
| Sex Distribution | 2 | 2005 | 34 | 0.060 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2017 | 100 | 0.060 |
Why?
|
| Ankle Injuries | 1 | 2005 | 7 | 0.060 |
Why?
|
| Osteogenesis | 1 | 2005 | 84 | 0.060 |
Why?
|
| Markov Chains | 1 | 2005 | 15 | 0.060 |
Why?
|
| Decision Making | 1 | 2006 | 95 | 0.050 |
Why?
|
| Fractures, Bone | 1 | 2005 | 37 | 0.050 |
Why?
|
| Bone Diseases | 1 | 2005 | 9 | 0.050 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2005 | 68 | 0.050 |
Why?
|
| Health Status Indicators | 1 | 2005 | 38 | 0.050 |
Why?
|
| Logistic Models | 2 | 2016 | 196 | 0.050 |
Why?
|
| Hospitalization | 1 | 2005 | 158 | 0.050 |
Why?
|
| Corrosion | 2 | 2015 | 54 | 0.050 |
Why?
|
| Suction | 2 | 2013 | 8 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 60 | 0.050 |
Why?
|
| Polyethylenes | 1 | 2002 | 18 | 0.050 |
Why?
|
| Registries | 1 | 2003 | 88 | 0.050 |
Why?
|
| Comorbidity | 1 | 2003 | 209 | 0.050 |
Why?
|
| Osteoarthritis, Hip | 1 | 2002 | 38 | 0.050 |
Why?
|
| Analgesics | 1 | 2022 | 48 | 0.040 |
Why?
|
| Pain Management | 1 | 2022 | 74 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2003 | 320 | 0.040 |
Why?
|
| Biomarkers | 2 | 2014 | 294 | 0.040 |
Why?
|
| Polyethylene | 1 | 2021 | 52 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 109 | 0.040 |
Why?
|
| Osteoarthritis | 1 | 2003 | 168 | 0.040 |
Why?
|
| Social Class | 1 | 2021 | 24 | 0.040 |
Why?
|
| Pain | 1 | 2022 | 193 | 0.040 |
Why?
|
| Statistics, Nonparametric | 2 | 2012 | 72 | 0.040 |
Why?
|
| Child | 1 | 2003 | 614 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2020 | 55 | 0.040 |
Why?
|
| Pain Measurement | 2 | 2012 | 211 | 0.040 |
Why?
|
| Patient Selection | 2 | 2012 | 111 | 0.040 |
Why?
|
| Adolescent | 1 | 2003 | 989 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2020 | 186 | 0.040 |
Why?
|
| Fracture Fixation, Internal | 1 | 2019 | 33 | 0.040 |
Why?
|
| Chicago | 2 | 2011 | 453 | 0.040 |
Why?
|
| Sex Factors | 2 | 2012 | 229 | 0.030 |
Why?
|
| Spondylarthritis | 1 | 2017 | 2 | 0.030 |
Why?
|
| Cost Savings | 1 | 2017 | 15 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 29 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2017 | 48 | 0.030 |
Why?
|
| Body Weight | 1 | 2017 | 72 | 0.030 |
Why?
|
| Linear Models | 1 | 2017 | 115 | 0.030 |
Why?
|
| Orthopedics | 1 | 2017 | 32 | 0.030 |
Why?
|
| Neutrophils | 1 | 2016 | 58 | 0.030 |
Why?
|
| Joints | 1 | 2016 | 43 | 0.030 |
Why?
|
| Joint Dislocations | 1 | 2016 | 24 | 0.030 |
Why?
|
| Patellar Ligament | 1 | 2015 | 21 | 0.030 |
Why?
|
| Geography | 2 | 2005 | 7 | 0.030 |
Why?
|
| Operative Time | 1 | 2014 | 38 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2014 | 27 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2014 | 39 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 324 | 0.020 |
Why?
|
| Anthropometry | 1 | 2012 | 20 | 0.020 |
Why?
|
| Chromium | 1 | 2012 | 35 | 0.020 |
Why?
|
| California | 1 | 2012 | 27 | 0.020 |
Why?
|
| Cobalt | 1 | 2012 | 46 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2012 | 12 | 0.020 |
Why?
|
| Titanium | 1 | 2012 | 99 | 0.020 |
Why?
|
| Causality | 1 | 2011 | 22 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2012 | 221 | 0.020 |
Why?
|
| Wound Closure Techniques | 1 | 2011 | 4 | 0.020 |
Why?
|
| Recurrence | 1 | 2011 | 126 | 0.020 |
Why?
|
| Arthralgia | 1 | 2012 | 56 | 0.020 |
Why?
|
| Acute Disease | 1 | 2011 | 90 | 0.020 |
Why?
|
| Age Factors | 1 | 2012 | 350 | 0.020 |
Why?
|
| Prognosis | 1 | 2012 | 363 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 464 | 0.020 |
Why?
|
| Analgesia | 1 | 2010 | 18 | 0.020 |
Why?
|
| Length of Stay | 1 | 2010 | 126 | 0.020 |
Why?
|
| Young Adult | 1 | 2012 | 863 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 2008 | 23 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2008 | 42 | 0.020 |
Why?
|
| Fracture Healing | 1 | 2008 | 22 | 0.020 |
Why?
|
| Connective Tissue | 1 | 2007 | 11 | 0.020 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2008 | 55 | 0.020 |
Why?
|
| Walking | 1 | 2008 | 108 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2008 | 81 | 0.020 |
Why?
|
| Materials Testing | 1 | 2007 | 70 | 0.020 |
Why?
|
| Medicare Part B | 1 | 2005 | 1 | 0.010 |
Why?
|
| Health Services for the Aged | 1 | 2005 | 4 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2005 | 156 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2003 | 43 | 0.010 |
Why?
|
| Medicare | 1 | 2003 | 59 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 152 | 0.010 |
Why?
|
| Animals | 1 | 2007 | 2092 | 0.010 |
Why?
|